Rothschild Investment LLC’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85K Buy
27
+2
+8% +$114 ﹤0.01% 2792
2026
Q1
$1.61K Sell
25
-7
-22% -$638 ﹤0.01% 2655
2025
Q4
$4.16K Sell
32
-3
-9% -$412 ﹤0.01% 1983
2025
Q3
$3.77K Hold
35
﹤0.01% 1839
2025
Q2
$3.23K Buy
35
+10
+40% +$785 ﹤0.01% 1743
2025
Q1
$2.21K Buy
25
+5
+25% +$434 ﹤0.01% 1830
2024
Q4
$1.54K Buy
20
+15
+300% +$1.05K ﹤0.01% 1961
2024
Q3
$212 Buy
+5
New +$169 ﹤0.01% 2704

Other funds holding WGS

Rothschild Investment LLC's WGS Position: Q2 2026 in Review

Rothschild Investment LLC increased its GeneDx Holdings (WGS) stake by 8% in Q2 2026, buying an estimated $114 and bringing the position to 27 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2792.

Rothschild Investment LLC first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.16K in Q4 2025. 77 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Rothschild Investment LLC held 27 shares of GeneDx Holdings worth $1.85K as of Q2 2026.
  • Rothschild Investment LLC bought 2 GeneDx Holdings shares in Q2 2026, an estimated $114.
  • GeneDx Holdings made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2792 holding.
  • Rothschild Investment LLC first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
  • Rothschild Investment LLC's GeneDx Holdings position peaked at $4.16K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.